Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer.

CONCLUSION: Despite extensive research and promising preclinical studies, a definite further agent in addition to fluoropyrimidines that consistently improves response rate has yet to be found.
PMID: 30311641 [PubMed - in process]

Source: The British Journal of Surgery - October 14, 2018 Category: Surgery Authors: Clifford R, Govindarajah N, Parsons JL, Gollins S, West NP, Vimalachandran D Tags: Br J Surg Source Type: research